Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma

SIMPLE SUMMARY: Although the majority of patients with myeloma who achieve undetectable minimal residual disease show prolonged survival, some of them relapse shortly afterwards. False-negative results due to hemodiluted bone marrow samples could explain this inconsistency, but there is no guidance...

Descripción completa

Detalles Bibliográficos
Autores principales: Puig, Noemí, Flores-Montero, Juan, Burgos, Leire, Cedena, María-Teresa, Cordón, Lourdes, Pérez, José-Juan, Sanoja-Flores, Luzalba, Manrique, Irene, Rodríguez-Otero, Paula, Rosiñol, Laura, Martínez-López, Joaquín, Mateos, María-Victoria, Lahuerta, Juan-José, Bladé, Joan, San Miguel, Jesús F., Orfao, Alberto, Paiva, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508317/
https://www.ncbi.nlm.nih.gov/pubmed/34638406
http://dx.doi.org/10.3390/cancers13194924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508317/
https://www.ncbi.nlm.nih.gov/pubmed/34638406
http://dx.doi.org/10.3390/cancers13194924

Ejemplares similares